Genmab is an international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.

 

Finance 150x110First Quarter 2017 Financial Results

Genmab published its First Quarter 2017 financial results and held an investor conference call on May 10. Click here to listen to the archived webcast. Click here to download the report. Click here to download the slide presentation. Click here to download the podcast. 

film thumnail croppedEmployee Film Featured at Annual General Meeting

Take a look behind the scenes in a video describing the important role teamwork and Genmab employees play in the company's success. Click here to watch. 

Join our teamCareer Opportunities at Genmab

Genmab is seeking new employees to join our teams in Copenhagen, Utrecht and Princeton.  Visit our Careers webpages to explore our current vacancies, learn about our culture and meet some of our team members.